KLAC KLA CORP
Optical Instruments & Lenses · Nasdaq · SEC CIK 319201 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.8%
TTM net income YoY24.1%
TTM EPS YoY227.9%
Revenue 3-yr CAGR12.6%
Net income 3-yr CAGR19.2%
Margins
Gross margin61.5%
Operating margin—
Net margin36.2%
FCF margin27.8%
EBITDA margin—
Returns
ROE91.4%
ROA30.3%
ROIC (approx.)—
Asset turnover0.84x
Leverage & solvency
Liabilities / assets64.6%
Debt / equity0.88x
Current ratio2.76x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.86x
Accruals ratio4.3%
Payout ratio21.1%
Capex / revenue3.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $13.58B | $12.16B | $9.81B | $10.50B | $9.21B |
| Cost of revenue | $5.26B | $4.75B | $3.93B | $4.22B | $3.59B |
| Gross profit | $8.32B | $7.40B | $5.88B | $6.28B | $5.62B |
| R&D expense | $1.53B | $1.36B | $1.28B | $1.30B | $1.11B |
| SG&A expense | $1.13B | $1.03B | $969.51M | $986.33M | $860.01M |
| Interest expense | $284.44M | $302.17M | $311.25M | $296.94M | $160.34M |
| Pretax income | $5.61B | $4.64B | $3.19B | $3.79B | $3.49B |
| Income tax | $775.15M | $582.80M | $428.14M | $401.84M | $167.18M |
| Net income | $4.83B | $4.06B | $2.76B | $3.39B | $3.32B |
| EPS (basic) | 3.68 | 3.05 | 2.04 | 24.28 | 22.07 |
| EPS (diluted) | 3.66 | 3.04 | 2.03 | 24.15 | 21.92 |
| Dividends declared per share | 0.80 | 0.68 | 0.56 | 5.20 | 4.20 |
| Weighted avg. shares (diluted) | 1.32B | 1.34B | 1.36B | 140.24M | 151.56M |
| Balance sheet | |||||
| Cash & equivalents | $1.65B | $2.08B | $1.98B | $1.93B | $1.58B |
| Receivables | $2.89B | $2.26B | $1.83B | $1.75B | $1.81B |
| Inventory | $3.65B | $3.21B | $3.03B | $2.88B | $2.15B |
| Current assets | $12.38B | $10.70B | $10.03B | $8.37B | $7.17B |
| PP&E, net | $1.38B | $1.25B | $1.11B | $1.03B | $849.93M |
| Goodwill | $1.79B | $1.79B | $2.02B | $2.28B | $2.32B |
| Intangibles | $255.84M | $444.79M | $668.76M | $935.30M | $1.19B |
| Total assets | $17.95B | $16.07B | $15.43B | $14.07B | $12.60B |
| Current liabilities | $4.30B | $4.09B | $4.66B | $3.74B | $2.87B |
| Short-term debt | — | $0 | $749.94M | $0 | $0 |
| Long-term debt | $5.89B | $5.88B | $5.88B | $5.89B | $6.66B |
| Total debt | $5.89B | $5.88B | $6.63B | $5.89B | $6.66B |
| Total liabilities | $11.60B | $11.38B | $12.07B | $11.15B | $11.20B |
| Shareholders' equity | $6.35B | $4.69B | $3.37B | $2.92B | $1.40B |
| Net debt | $4.24B | $3.81B | $4.65B | $3.96B | $5.08B |
| Shares outstanding | 1.31B | 1.32B | 134.43M | 136.75M | 141.80M |
| Cash flow statement | |||||
| Operating cash flow | $4.14B | $4.08B | $3.31B | $3.67B | $3.31B |
| Capital expenditure | $375.94M | $335.26M | $277.38M | $341.59M | $307.32M |
| Free cash flow | $3.77B | $3.75B | $3.03B | $3.33B | $3.01B |
| Investing cash flow | -$1.19B | -$202.48M | -$1.48B | -$482.57M | -$876.46M |
| Financing cash flow | -$3.39B | -$3.79B | -$1.78B | -$2.83B | -$2.26B |
| Depreciation & amortization | $393.98M | $394.09M | $401.73M | $415.11M | $363.34M |
| Stock-based compensation | $310.17M | $265.01M | $212.69M | $171.42M | $126.92M |
| Dividends paid | $1.06B | $904.59M | $773.04M | $732.56M | $638.53M |
| Share buybacks | $2.29B | $2.15B | $1.74B | $1.31B | $3.97B |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.